Clinical trials: Neuroendocrine Tumors, NET
Neuroendocrine Neoplasms (Tumours), Neuroendocrine Tumors
Study to Assess the Safety and Effectiveness of Novel Radiopharmaceutical Terbium-161 DOTATATE in Metastatic Neuroendocrine Tumors
Gastro-enteropancreatic Neuro-endocrine tumors (GEP-NETs) are rare slow-growing cancers which commonly involve the abdominal organs like liver, stomach, intestines and pancreas.
- Conditions
- Neuroendocrine Neoplasms (Tumours), Neuroendocrine Tumors, Metastatic Neuroendocrine Tumors
- Trial name
- TENET (NCT07404176)
- Testing
- Terbium 161
- Where
- 2 sites in India
- Volunteers
- 20 people
- Sponsor
- Tata Memorial Hospital